Cargando…
Increased Risk of Site-Specific Cancer in People with Type 2 Diabetes: A National Cohort Study
A retrospective cohort design was used with the objective to evaluate cancer risk among people with type 2 diabetes mellitus (T2DM) in Lithuania. The cohort was established by identifying all patients with the first diagnosis of T2DM in the National Health Insurance Fund database during 2000–2012. C...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6982113/ https://www.ncbi.nlm.nih.gov/pubmed/31905811 http://dx.doi.org/10.3390/ijerph17010246 |
_version_ | 1783491240640118784 |
---|---|
author | Linkeviciute-Ulinskiene, Donata Patasius, Ausvydas Zabuliene, Lina Stukas, Rimantas Smailyte, Giedre |
author_facet | Linkeviciute-Ulinskiene, Donata Patasius, Ausvydas Zabuliene, Lina Stukas, Rimantas Smailyte, Giedre |
author_sort | Linkeviciute-Ulinskiene, Donata |
collection | PubMed |
description | A retrospective cohort design was used with the objective to evaluate cancer risk among people with type 2 diabetes mellitus (T2DM) in Lithuania. The cohort was established by identifying all patients with the first diagnosis of T2DM in the National Health Insurance Fund database during 2000–2012. Cancer cases were identified by record linkage with the Lithuanian Cancer Registry. Standardized incidence ratios (SIRs) were calculated. Of the 127,290 people that were included, 5959 cases of cancer in men and 6661 cancer cases in women with T2DM were observed. A statistically significant increase in risk for all cancer sites was observed in women, SIR 1.16 (95% CI 1.14–1.19), but not in men, SIR 1.00 (95% CI 0.98–1.03). Among males, a significant increase of liver (SIR 2.11, 95% CI 1.79–2.49]), pancreas (SIR 1.77, 95% CI 1.57–1.99), kidney (SIR 1.46 95% CI 1.31–1.62), thyroid (SIR 1.83, 95% CI 1.32–2.54), colorectal (SIR 1.23, 95% CI 1.14–1.31]), skin melanoma (SIR 1.40, 95% CI 1.11–1.76), and non–melanoma skin (SIR 1.14, 95% CI 1.05–1.23) cancer was observed. For females with T2DM, a significant increase in risk of cancer of the liver (SIR 1.45, 95% CI 1.17–1.79), pancreas (SIR 1.74, 95% CI 1.56–1.93), kidney (SIR = 1.43, 95% CI 1.28–1.60), thyroid (SIR = 1.40, 95% CI 1.22–1.62), breast (SIR = 1.24, 95% CI 1.17–1.31), and corpus uteri (SIR 2.07, 95% CI 1.93–2.21) was observed. In conclusion, people with T2DM in Lithuania had an increased risk of site-specific cancer. |
format | Online Article Text |
id | pubmed-6982113 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-69821132020-02-07 Increased Risk of Site-Specific Cancer in People with Type 2 Diabetes: A National Cohort Study Linkeviciute-Ulinskiene, Donata Patasius, Ausvydas Zabuliene, Lina Stukas, Rimantas Smailyte, Giedre Int J Environ Res Public Health Article A retrospective cohort design was used with the objective to evaluate cancer risk among people with type 2 diabetes mellitus (T2DM) in Lithuania. The cohort was established by identifying all patients with the first diagnosis of T2DM in the National Health Insurance Fund database during 2000–2012. Cancer cases were identified by record linkage with the Lithuanian Cancer Registry. Standardized incidence ratios (SIRs) were calculated. Of the 127,290 people that were included, 5959 cases of cancer in men and 6661 cancer cases in women with T2DM were observed. A statistically significant increase in risk for all cancer sites was observed in women, SIR 1.16 (95% CI 1.14–1.19), but not in men, SIR 1.00 (95% CI 0.98–1.03). Among males, a significant increase of liver (SIR 2.11, 95% CI 1.79–2.49]), pancreas (SIR 1.77, 95% CI 1.57–1.99), kidney (SIR 1.46 95% CI 1.31–1.62), thyroid (SIR 1.83, 95% CI 1.32–2.54), colorectal (SIR 1.23, 95% CI 1.14–1.31]), skin melanoma (SIR 1.40, 95% CI 1.11–1.76), and non–melanoma skin (SIR 1.14, 95% CI 1.05–1.23) cancer was observed. For females with T2DM, a significant increase in risk of cancer of the liver (SIR 1.45, 95% CI 1.17–1.79), pancreas (SIR 1.74, 95% CI 1.56–1.93), kidney (SIR = 1.43, 95% CI 1.28–1.60), thyroid (SIR = 1.40, 95% CI 1.22–1.62), breast (SIR = 1.24, 95% CI 1.17–1.31), and corpus uteri (SIR 2.07, 95% CI 1.93–2.21) was observed. In conclusion, people with T2DM in Lithuania had an increased risk of site-specific cancer. MDPI 2019-12-30 2020-01 /pmc/articles/PMC6982113/ /pubmed/31905811 http://dx.doi.org/10.3390/ijerph17010246 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Linkeviciute-Ulinskiene, Donata Patasius, Ausvydas Zabuliene, Lina Stukas, Rimantas Smailyte, Giedre Increased Risk of Site-Specific Cancer in People with Type 2 Diabetes: A National Cohort Study |
title | Increased Risk of Site-Specific Cancer in People with Type 2 Diabetes: A National Cohort Study |
title_full | Increased Risk of Site-Specific Cancer in People with Type 2 Diabetes: A National Cohort Study |
title_fullStr | Increased Risk of Site-Specific Cancer in People with Type 2 Diabetes: A National Cohort Study |
title_full_unstemmed | Increased Risk of Site-Specific Cancer in People with Type 2 Diabetes: A National Cohort Study |
title_short | Increased Risk of Site-Specific Cancer in People with Type 2 Diabetes: A National Cohort Study |
title_sort | increased risk of site-specific cancer in people with type 2 diabetes: a national cohort study |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6982113/ https://www.ncbi.nlm.nih.gov/pubmed/31905811 http://dx.doi.org/10.3390/ijerph17010246 |
work_keys_str_mv | AT linkeviciuteulinskienedonata increasedriskofsitespecificcancerinpeoplewithtype2diabetesanationalcohortstudy AT patasiusausvydas increasedriskofsitespecificcancerinpeoplewithtype2diabetesanationalcohortstudy AT zabulienelina increasedriskofsitespecificcancerinpeoplewithtype2diabetesanationalcohortstudy AT stukasrimantas increasedriskofsitespecificcancerinpeoplewithtype2diabetesanationalcohortstudy AT smailytegiedre increasedriskofsitespecificcancerinpeoplewithtype2diabetesanationalcohortstudy |